Ticagrelor and Aspirin or Aspirin Alone After Coronary Surgery for Acute Coronary Syndrome [1]
This article examines the effects of adding ticagrelor to aspirin in patients undergoing coronary artery bypass grafting (CABG) for acute coronary syndrome. The randomized trial involved 2,201 patients and found no significant difference in the primary outcome of death, myocardial infarction, stroke, or repeat coronary revascularization between the ticagrelor-plus-aspirin group and the aspirin-alone group after one year. However, the ticagrelor-plus-aspirin group had a higher incidence of major bleeding, suggesting the need for careful consideration regarding dual antiplatelet therapy in this population.